Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

Dr.Ci:Labo

TENMA

SAKATA INX

和光純薬工業

kyowa Hakko Kirin

栄研化学

SATO PHARMACEUTICAL

TAKASAGO INTERNATIONAL

積水樹脂

TOWA PHARMACEUTICAL

JSP

C.Uyemura

Milbon

KAKEN PHARMACEUTICAL

Noevir Holdings

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

ROHM

Nittetsu Mining

KIKUSUI ELECTRONICS etc.

KIKUSUI ELECTRONICS etc.

日本アビオニクス

Financial Indicator Details: 栄研化学 (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: 栄研化学 (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	4.35% (-12.05%)	4.52% (-0.50%)	6.06% (1.53%)	5.27% (-1.67%)	8.56% (3.05%)
C/F margin (Industry Average)	7.22% (-3.31%)	10.09% (8.51%)	8.02% (7.04%)	6.18% (6.35%)	7.77% (8.25%)
ROA (Industry Average)	4.07% (0.52%)	4.14% (1.04%)	5.12% (2.07%)	4.40% (0.06%)	6.98% (2.71%)
ROE (Industry Average)	6.17% (-1.43%)	6.29% (0.03%)	8.17% (2.96%)	6.80% (4.68%)	10.35% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	4.71% (5.01%)	6.10% (2.61%)	4.92% (-0.40%)	10.34% (8.16%)
Sales growth (Industry Average)	- (-)	2.78% (-2.67%)	2.68% (5.36%)	0.50% (1.07%)	3.40% (2.24%)
Net profit growth (Industry Average)	- (-)	6.77% (203.46%)	37.72% (63.25%)	-12.67% (3.89%)	68.01% (90.38%)
Operating C/F growth (Industry Average)	- (-)	43.56% (275.10%)	-18.34% (35.09%)	-22.55% (-6.09%)	30.06% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	65.98% (53.80%)	65.75% (54.51%)	62.65% (55.00%)	64.78% (53.59%)	67.38% (56.30%)
Liquidity ratio (Industry Average)	235.03% (217.72%)	234.49% (225.70%)	214.72% (237.55%)	209.05% (239.89%)	258.11% (236.21%)
C/F ratio current liabilities (Industry Average)	425.96% (777.21%)	323.47% (303.31%)	425.18% (434.79%)	554.46% (929.73%)	439.81% (573.30%)
Quick ratio (Industry Average)	162.98% (138.97%)	173.35% (148.85%)	155.15% (156.17%)	151.33% (160.84%)	191.61% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	107.39day (83.89day)	110.88day (94.27day)	113.18day (93.96day)	119.62day (97.92day)	117.33day (98.27day)
Inventory turnover (Industry Average)	70.50day (54.45day)	58.40day (52.58day)	55.14day (52.64day)	56.76day (56.59day)	65.99day (58.68day)
Payable turnover (Industry Average)	71.66day (45.01day)	71.54day (49.82day)	74.34day (49.52day)	72.52day (52.10day)	47.98day (51.12day)
Working capita turnover (Industry Average)	106.23day (93.32day)	97.74day (97.02day)	93.98day (97.08day)	103.86day (102.41day)	135.33day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	52.02% (34.57%)	3.52% (1.49%)	14.52% (-3.85%)	19.06% (21.16%)
Dividend Yield (Industry Average)	4.49% (3.20%)	1.95% (1.93%)	2.14% (2.17%)	2.24% (2.45%)	2.07% (2.07%)
PER (Industry Average)	11.81% (25.22%)	16.82% (23.06%)	12.64% (16.22%)	16.58% (29.19%)	11.75% (16.58%)
PBR (Industry Average)	0.72% (0.86%)	1.05% (1.06%)	1.03% (1.04%)	1.12% (0.95%)	1.21% (1.08%)
PCFR (Industry Average)	7.11% (7.18%)	7.53% (9.23%)	9.55% (-2.43%)	14.13% (9.50%)	12.93% (7.56%)
PSR (Industry Average)	0.51% (0.77%)	0.76% (0.88%)	0.76% (1.10%)	0.87% (0.90%)	1.00% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	4.66% (-27.66%)	4.74% (-4.34%)	6.20% (-5.37%)	5.13% (-10.69%)	8.38% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	4.31% (0.52%)	4.28% (0.92%)	5.15% (1.42%)	4.23% (-0.27%)	6.77% (1.53%)
ROE (Industry Average)	6.48% (-0.84%)	6.47% (-0.46%)	8.16% (1.81%)	6.49% (3.42%)	10.02% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	4.90% (3.64%)	6.42% (3.03%)	4.53% (0.04%)	9.40% (3.91%)
Sales growth (Industry Average)	- (-)	2.77% (-3.48%)	2.69% (6.70%)	0.52% (0.75%)	3.32% (-1.74%)
Net profit growth (Industry Average)	- (-)	4.68% (166.48%)	34.22% (43.48%)	-16.84% (-47.04%)	68.84% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	66.45% (56.79%)	66.19% (57.65%)	63.18% (57.17%)	65.20% (55.93%)	67.62% (57.57%)
Liquidity ratio (Industry Average)	233.68% (337.22%)	231.39% (276.75%)	211.43% (266.94%)	207.24% (314.47%)	256.93% (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	160.92% (167.28%)	169.03% (183.78%)	152.19% (174.83%)	148.88% (228.06%)	189.76% (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	107.37day (87.55day)	110.89day (98.39day)	113.28day (95.88day)	119.68day (98.58day)	117.36day (67.18day)
Inventory turnover (Industry Average)	70.39day (50.17day)	58.41day (48.43day)	54.98day (47.43day)	56.33day (50.67day)	65.52day (38.21day)
Payable turnover (Industry Average)	74.59day (45.70day)	72.57day (51.63day)	76.86day (51.13day)	79.62day (53.57day)	48.37day (34.24day)
Working capita turnover (Industry Average)	103.16day (92.02day)	96.74day (95.19day)	91.40day (92.19day)	96.39day (95.69day)	134.51day (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	52.02% (34.46%)	3.52% (3.11%)	14.52% (-3.30%)	19.06% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	11.03% (34.12%)	16.02% (27.80%)	12.36% (13.58%)	17.02% (22.26%)	12.00% (26.42%)
PBR (Industry Average)	0.71% (0.97%)	1.03% (1.21%)	1.00% (1.17%)	1.10% (1.08%)	1.20% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.51% (3.42%)	0.76% (4.34%)	0.76% (3.67%)	0.87% (4.37%)	1.00% (10.14%)

Financial Indicator Details: 栄研化学

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	4.35%	4.52%	6.06%	5.27%	8.56%
C/F margin	7.22%	10.09%	8.02%	6.18%	7.77%
ROA	4.07%	4.14%	5.12%	4.40%	6.98%
ROE	6.17%	6.29%	8.17%	6.80%	10.35%
Recurring margin	7.77%	7.49%	10.06%	9.17%	9.81%
EBIT margin	7.26%	7.20%	9.63%	8.70%	13.10%
EBITDA margin	10.73%	10.63%	12.98%	12.37%	16.73%
NOPAT margin	4.35%	4.32%	5.77%	5.22%	7.86%
Sales SG rates	57.49%	59.52%	58.33%	58.16%	59.56%
Sales SG&A rates	35.49%	33.38%	31.83%	33.30%	31.53%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	3.46%	3.43%	3.34%	3.66%	3.63%
Capital expenditures net sales ratio	-3.00%	-2.98%	-14.81%	-6.28%	-3.35%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	29.88%	-14.09%	-12.40%	80.69%
Equity growth	-	4.71%	6.10%	4.92%	10.34%
Total assets growth	-	5.08%	11.35%	1.47%	6.08%
Sales growth	-	2.78%	2.68%	0.50%	3.40%
Net profit growth	-	6.77%	37.72%	-12.67%	68.01%
Operating C/F growth	-	43.56%	-18.34%	-22.55%	30.06%
Recurring profit growth	-	-0.93%	37.99%	-8.36%	10.57%
EBIT growth	-	1.95%	37.35%	-9.19%	55.70%
EBITDA growth	-	1.89%	25.32%	-4.22%	39.88%
NOPAT growth	-	1.95%	37.35%	-9.19%	55.70%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	65.98%	65.75%	62.65%	64.78%	67.38%
Liquidity ratio	235.03%	234.49%	214.72%	209.05%	258.11%
C/F ratio current liabilities	425.96%	323.47%	425.18%	554.46%	439.81%
Quick ratio	162.98%	173.35%	155.15%	151.33%	191.61%
Fixed ratio	32.86%	31.00%	47.19%	48.81%	29.19%
D/E ratio	-	-	7.33%	5.65%	3.13%
Loan to Value Ratio	-	-	4.59%	3.66%	2.11%
Business investment C/F ratio	-41.60%	-29.60%	-184.53%	-101.69%	-43.17%
Liabilities with interest growth	-	-	-	-19.06%	-38.87%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	75.73day	95.69day	80.05day	69.76day	121.91day
Receivables turnover	107.39day	110.88day	113.18day	119.62day	117.33day
Inventory turnover	70.50day	58.40day	55.14day	56.76day	65.99day
Fixed assets turnover	84.56day	81.26day	127.82day	138.03day	88.08day
Total asset turnover	389.90day	398.62day	432.27day	436.43day	447.73day
Payable turnover	71.66day	71.54day	74.34day	72.52day	47.98day
Capital turnover	96.40day	93.78day	91.33day	90.87day	87.88day
Equity turnover	257.28day	262.11day	270.82day	282.74day	301.72day
Working capita turnover	106.23day	97.74day	93.98day	103.86day	135.33day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 5 B	¥ 7 B	¥ 6 B	¥ 5 B	¥ 9 B
Accounts receivable-trade	¥ 7 B	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B
Other Current Assets	¥ 13 B	¥ 13 B	¥ 14 B	¥ 14 B	¥ 15 B
Current Assets	¥ 18 B	¥ 20 B	¥ 20 B	¥ 19 B	¥ 25 B
Tangible Assets	¥ 6 B	¥ 5 B	¥ 9 B	¥ 10 B	¥ 6 B
Intangible Assets	¥ 465 M	¥ 430 M	¥ 380 M	¥ 361 M	¥ 429 M
Investment etc.	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Total Assets	¥ 27 B	¥ 29 B	¥ 32 B	¥ 33 B	¥ 35 B
Current Liabilities	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B	¥ 9 B
Fixed Liabilities	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B
Liabilities with interest	-	-	¥ 1 B	¥ 1 B	¥ 742 M
Net Assets	¥ 18 B	¥ 19 B	¥ 20 B	¥ 21 B	¥ 23 B
Capital stock	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Capital surplus etc.	¥ 11 B	¥ 12 B	¥ 13 B	¥ 14 B	¥ 16 B
Liabilities and net assets	¥ 27 B	¥ 29 B	¥ 32 B	¥ 33 B	¥ 35 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 26 B	¥ 26 B	¥ 27 B	¥ 27 B	¥ 28 B
Cost of Sales	¥ 15 B	¥ 15 B	¥ 16 B	¥ 16 B	¥ 17 B
Gross profit	¥ 11 B	¥ 10 B	¥ 11 B	¥ 11 B	¥ 11 B
Other income	¥ 282 M	¥ 139 M	¥ 136 M	¥ 330 M	¥ 1 B
SG&A	¥ 9 B	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B
Other expenses	¥ 973 M	¥ 827 M	¥ 1 B	¥ 1 B	¥ 1 B
Net income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Operating income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Ordinary Income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
EBITDA	¥ 2 B	¥ 2 B	¥ 3 B	¥ 3 B	¥ 4 B
Income before income taxes	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B
Depreciation	¥ 906 M	¥ 922 M	¥ 923 M	¥ 1 B	¥ 1 B
R&D expenses	-	-	-	-	-
Income taxes	¥ 766 M	¥ 718 M	¥ 970 M	¥ 929 M	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B	¥ 2 B
Investment CF	¥ -1 B	¥ -660 M	¥ -4 B	¥ -1 B	¥ 3 B
Financial CF	¥ -1 B	¥ -431 M	¥ 954 M	¥ -964 M	¥ -1 B
Foreign Exchange Effects	¥ -8 M	-	¥ -30 M	¥ 4 M	-
Net Change in Cash	¥ -1 B	¥ 1 B	¥ -991 M	¥ -880 M	¥ 4 B
Free CF	¥ 711 M	¥ 2 B	¥ -1 B	¥ 79 M	¥ 5 B
Capital expenditures	¥ -785 M	¥ -802 M	¥ -4 B	¥ -1 B	¥ -962 M
Cash dividends paid	¥ -604 M	¥ -399 M	¥ -454 M	¥ -544 M	¥ -599 M
Repayment loans	-	-	-	¥ -286 M	¥ -472 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -604 M	¥ -399 M	¥ -454 M	¥ -544 M	¥ -599 M
Net income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Purchase of treasury stock	¥ -1 B	¥ 4 M	¥ 5 M	-	¥ 9 M
Other Change in Stockholders Equity	¥ 1 M	¥ 1 M	¥ -1 M	¥ -1 M	-
Other Change in Net Assets	¥ -151 M	¥ 48 M	¥ -47 M	¥ 93 M	¥ 356 M
Net Change in Net Assets	¥ -960 M	¥ 868 M	¥ 1 B	¥ 1 B	¥ 2 B

Financial Indicator Details: 栄研化学

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	4.66%	4.74%	6.20%	5.13%	8.38%
C/F margin	-	-	-	-	-
ROA	4.31%	4.28%	5.15%	4.23%	6.77%
ROE	6.48%	6.47%	8.16%	6.49%	10.02%
Recurring margin	8.08%	7.70%	10.20%	9.04%	9.64%
EBIT margin	7.55%	7.41%	9.75%	8.55%	12.94%
EBITDA margin	7.55%	7.41%	9.75%	8.55%	12.98%
NOPAT margin	4.53%	4.44%	5.85%	5.13%	7.76%
Sales SG rates	57.45%	59.64%	58.57%	58.54%	59.82%
Sales SG&A rates	35.19%	32.95%	31.51%	32.94%	31.17%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	-	-	-	-	0.04%
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	27.76%	-13.34%	-11.99%	84.81%
Equity growth	-	4.90%	6.42%	4.53%	9.40%
Total assets growth	-	5.31%	11.51%	1.29%	5.48%
Sales growth	-	2.77%	2.69%	0.52%	3.32%
Net profit growth	-	4.68%	34.22%	-16.84%	68.84%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	-2.03%	36.02%	-10.87%	10.13%
EBIT growth	-	0.75%	35.19%	-11.82%	56.26%
EBITDA growth	-	0.75%	35.19%	-11.82%	56.81%
NOPAT growth	-	0.75%	35.19%	-11.82%	56.26%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	66.45%	66.19%	63.18%	65.20%	67.62%
Liquidity ratio	233.68%	231.39%	211.43%	207.24%	256.93%
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	160.92%	169.03%	152.19%	148.88%	189.76%
Fixed ratio	29.52%	27.79%	43.58%	45.05%	26.05%
D/E ratio	-	-	7.15%	5.54%	3.09%
Loan to Value Ratio	-	-	4.52%	3.61%	2.09%
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-	-	-19.06%	-38.87%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	73.04day	90.81day	76.62day	67.08day	119.99day
Receivables turnover	107.37day	110.89day	113.28day	119.68day	117.36day
Inventory turnover	70.39day	58.41day	54.98day	56.33day	65.52day
Fixed assets turnover	77.43day	74.42day	120.92day	129.98day	79.60day
Total asset turnover	394.67day	404.42day	439.13day	442.48day	451.75day
Payable turnover	74.59day	72.57day	76.86day	79.62day	48.37day
Capital turnover	96.40day	93.80day	91.33day	90.86day	87.94day
Equity turnover	262.29day	267.72day	277.44day	288.52day	305.50day
Working capita turnover	103.16day	96.74day	91.40day	96.39day	134.51day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 5 B	¥ 6 B	¥ 5 B	¥ 5 B	¥ 9 B
Accounts receivable-trade	¥ 7 B	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B
Other Current Assets	¥ 13 B	¥ 13 B	¥ 14 B	¥ 14 B	¥ 15 B
Current Assets	¥ 18 B	¥ 20 B	¥ 19 B	¥ 19 B	¥ 25 B
Tangible Assets	¥ 5 B	¥ 5 B	¥ 9 B	¥ 9 B	¥ 6 B
Intangible Assets	¥ 301 M	¥ 257 M	¥ 223 M	¥ 203 M	¥ 249 M
Investment etc.	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Total Assets	¥ 28 B	¥ 29 B	¥ 33 B	¥ 33 B	¥ 35 B
Current Liabilities	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B	¥ 9 B
Fixed Liabilities	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B
Liabilities with interest	-	-	¥ 1 B	¥ 1 B	¥ 742 M
Net Assets	¥ 18 B	¥ 19 B	¥ 20 B	¥ 21 B	¥ 23 B
Capital stock	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Capital surplus etc.	¥ 11 B	¥ 12 B	¥ 14 B	¥ 15 B	¥ 17 B
Liabilities and net assets	¥ 28 B	¥ 29 B	¥ 33 B	¥ 33 B	¥ 35 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 26 B	¥ 26 B	¥ 27 B	¥ 27 B	¥ 28 B
Cost of Sales	¥ 15 B	¥ 16 B	¥ 16 B	¥ 16 B	¥ 17 B
Gross profit	¥ 11 B	¥ 10 B	¥ 11 B	¥ 11 B	¥ 11 B
Other income	¥ 275 M	¥ 114 M	¥ 127 M	¥ 298 M	¥ 1 B
SG&A	¥ 9 B	¥ 8 B	¥ 8 B	¥ 9 B	¥ 8 B
Other expenses	¥ 973 M	¥ 824 M	¥ 1 B	¥ 1 B	¥ 1 B
Net income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Operating income	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Ordinary Income	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
EBITDA	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B
Income before income taxes	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B
Depreciation	-	-	-	-	¥ 13 M
R&D expenses	-	-	-	-	-
Income taxes	¥ 766 M	¥ 718 M	¥ 971 M	¥ 929 M	¥ 1 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -604 M	¥ -399 M	¥ -454 M	¥ -544 M	¥ -599 M
Net income	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 2 B
Purchase of treasury stock	¥ -1 B	¥ 4 M	¥ 5 M	-	¥ 9 M
Other Change in Stockholders Equity	¥ 2 M	¥ 1 M	-	¥ -1 M	¥ 1 M
Other Change in Net Assets	¥ -15 M	¥ 40 M	¥ 3 M	¥ 73 M	¥ 247 M
Net Change in Net Assets	¥ -743 M	¥ 920 M	¥ 1 B	¥ 950 M	¥ 2 B

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: 栄研化学 (Annual )

Statement Type

Annual : 栄研化学

First quarter : 栄研化学

Second quarter : 栄研化学

Third quarter : 栄研化学

Analysis Menu

Outline : 栄研化学

Statement : 栄研化学

Rating : 栄研化学

Indicator : 栄研化学

Download : 栄研化学

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo台東区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
栄研化学	4549	TSE 1st	Chemicals	3	Annual	A

Related Company

Central Glass (Sales ¥ 173 B)

TOYO INK SC HOLDINGS (Sales ¥ 248 B)

Sumitomo Bakelite (Sales ¥ 183 B)

TENMA (Sales ¥ 58 B)

小林製薬 (Sales ¥ 121 B)

KAKEN PHARMACEUTICAL (Sales ¥ 87 B)

TOWA PHARMACEUTICAL (Sales ¥ 55 B)

日本新薬 (Sales ¥ 69 B)

TAKASAGO INTERNATIONAL (Sales ¥ 118 B)

ZEON (Sales ¥ 250 B)

SATO PHARMACEUTICAL (Sales ¥ 38 B)

TOAGOSEI CO (Sales ¥ 148 B)

C.Uyemura (Sales ¥ 37 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .